DNMT3A and hepatocellular carcinoma: In HCV-related cohorts, circulating DNMT3A mRNA has shown strong diagnostic performance in distinguishing HCC from cirrhosis, with an AUC of 0.958 at a defined cutoff, and with sensitivity and specificity values of 80.8% and 95.6%, respectively [19].